glp-1 therapy manhattan in NYC GLP 1 Weight Loss Program

FDA cracking down telehealth companies On March 2, the FDA announced it sent 30 letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites

The active ingredient in Mounjaro, tirzepatide, appears to be more effective than semaglutide, which is the active drug in Ozempic and Wegovy

Tax-advantaged accounts like flexible savings accounts (FSAs) and health savings accounts (HSAs) can also help

Patients often report significant reductions in inflammatory markers within days of starting treatment, leading to improved overall health and well-being

Yet hair loss has been observed in clinical data